Document is current
Any future updates will be listed below
-
Authors
Shah, Manasee V.
Solem, Caitlyn T.
Liao, Anne
Bell, Kelly F.
Wang, Yao
Yang, Hongbo
Meng, Yan
Ye, Mingchen
Tapan, Umit https://orcid.org/0000-0002-3906-3004
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 15 June 2025
Accepted: 18 August 2025
First Online: 29 August 2025
Declarations
:
: Manasee V. Shah, Caitlyn Solem, Anne Liao, and Kelly F. Bell are employees of and may hold stock in GSK. Yao Wang, Hongbo Yang, and Yan Meng are employees of Analysis Group, and Mingchen Ye was an employee of Analysis Group at the time of the study, which received consulting fees from GSK to conduct this study. Umit Tapan has received an educational grant from Pfizer, served as an advisory board member for Sanofi/Genzyme/Regeneron and Pfizer, served as a speaker at AstraZeneca- and TD Cowen-sponsored symposia, and is an outside consultant for GSK.
: This study received institutional board approval from Pearl IRB on November 23, 2022 and was conducted in accordance with the protocol, applicable regulations, and guidelines governing clinical study conduct and the ethical principles of the Declaration of Helsinki. All subjects provided informed consent to participate in the study. No identifying information was collected.
